156 related articles for article (PubMed ID: 29463556)
1.
Tao Y; Sturgis EM; Huang Z; Wang Y; Wei P; Wang JR; Wei Q; Li G
Clin Cancer Res; 2018 May; 24(9):2225-2233. PubMed ID: 29463556
[No Abstract] [Full Text] [Related]
2. A genetic variant within MDM4 3'UTR miRNA binding site is associated with HPV16-positive tumors and survival of oropharyngeal cancer.
Zhang Y; Sturgis EM; Wei P; Liu H; Wang Z; Ma Y; Liu C; Gu KJ; Wei Q; Li G
Mol Carcinog; 2019 Dec; 58(12):2276-2285. PubMed ID: 31513313
[TBL] [Abstract][Full Text] [Related]
3. Potentially functional variants of p14ARF are associated with HPV-positive oropharyngeal cancer patients and survival after definitive chemoradiotherapy.
Song X; Sturgis EM; Huang Z; Li X; Li C; Wei Q; Li G
Carcinogenesis; 2014 Jan; 35(1):62-8. PubMed ID: 24104554
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-10 promoter variants predict HPV-positive tumors and survival of squamous cell carcinoma of the oropharynx.
Jin L; Sturgis EM; Cao X; Song X; Salahuddin T; Wei Q; Li G
FASEB J; 2013 Jun; 27(6):2496-503. PubMed ID: 23430974
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in microRNA-binding sites of DNA repair genes as predictors of recurrence in patients with squamous cell carcinoma of the oropharynx.
Zhu L; Sturgis EM; Zhang H; Lu Z; Tao Y; Wei Q; Li G
Int J Cancer; 2017 Oct; 141(7):1355-1364. PubMed ID: 28646528
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in TNF-α promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy.
Zhang C; Sturgis EM; Zheng H; Song X; Wei P; Jin L; Chao L; Wei Q; Li G
Int J Cancer; 2014 Apr; 134(8):1907-15. PubMed ID: 24122460
[TBL] [Abstract][Full Text] [Related]
7. Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancer.
Guan X; Sturgis EM; Lei D; Liu Z; Dahlstrom KR; Wei Q; Li G
Clin Cancer Res; 2010 Mar; 16(5):1416-22. PubMed ID: 20179236
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte telomere length predicts clinical outcomes of HPV-positive oropharyngeal cancer patients after definitive radiotherapy.
Luo X; Sturgis EM; Yang Z; Sun Y; Wei P; Liu Z; Wei Q; Li G
Carcinogenesis; 2019 Jul; 40(6):735-741. PubMed ID: 30721961
[TBL] [Abstract][Full Text] [Related]
9. Association of genetic variants with tumor HPV16 status and survival in squamous cell carcinoma of the oropharynx.
Feng Y; Li Y; Zhang Y; Zheng H; Li G
Oral Oncol; 2016 May; 56():78-83. PubMed ID: 27086490
[TBL] [Abstract][Full Text] [Related]
10. Pre-microRNA variants predict HPV16-positive tumors and survival in patients with squamous cell carcinoma of the oropharynx.
Guan X; Sturgis EM; Song X; Liu Z; El-Naggar AK; Wei Q; Li G
Cancer Lett; 2013 Apr; 330(2):233-40. PubMed ID: 23219900
[TBL] [Abstract][Full Text] [Related]
11. E2F transcription factor 2 variants as predictive biomarkers for recurrence risk in patients with squamous cell carcinoma of the oropharynx.
Li Y; Sturgis EM; Zhu L; Cao X; Wei Q; Zhang H; Li G
Mol Carcinog; 2017 Apr; 56(4):1335-1343. PubMed ID: 27864908
[TBL] [Abstract][Full Text] [Related]
12. Functional Genetic Variants in TGFβ1 and TGFβR1 in miRNA-Binding Sites Predict Outcomes in Patients with HPV-positive Oropharyngeal Squamous Cell Carcinoma.
Niu Z; Sun P; Liu H; Wei P; Wu J; Huang Z; Gross ND; Shete S; Wei Q; Zafereo ME; Calin GA; Li G
Clin Cancer Res; 2023 Aug; 29(16):3081-3091. PubMed ID: 37327315
[TBL] [Abstract][Full Text] [Related]
13. GWAS-identified telomere length associated genetic variants predict risk of recurrence of HPV-positive oropharyngeal cancer after definitive radiotherapy.
Sun P; Wei P; Liu H; Wu J; Gross ND; Sikora AG; Wei Q; Shete S; Zafereo ME; Liu J; Li G
EBioMedicine; 2023 Aug; 94():104722. PubMed ID: 37487414
[TBL] [Abstract][Full Text] [Related]
14. HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx.
Dahlstrom KR; Anderson KS; Cheng JN; Chowell D; Li G; Posner M; Sturgis EM
Clin Cancer Res; 2015 Jun; 21(12):2861-9. PubMed ID: 26078432
[TBL] [Abstract][Full Text] [Related]
15. Modifying effect of mouse double minute-2 promoter variants on risk of recurrence for patients with squamous cell carcinoma of oropharynx.
Zhang Y; Sturgis EM; Li Y; Wei Q; Huang Z; Li G
Sci Rep; 2017 Jan; 7():39765. PubMed ID: 28045062
[TBL] [Abstract][Full Text] [Related]
16. Mouse double minute 4 variants modify susceptibility to risk of recurrence in patients with squamous cell carcinoma of the oropharynx.
Lu Z; Sturgis EM; Zhu L; Zhang H; Tao Y; Wei P; Wei Q; Li G
Mol Carcinog; 2018 Mar; 57(3):361-369. PubMed ID: 29073727
[TBL] [Abstract][Full Text] [Related]
17. A functional variant at miRNA-122 binding site in IL-1α 3' UTR predicts risk and HPV-positive tumours of oropharyngeal cancer.
Zhang Y; Sturgis EM; Sun Y; Sun C; Wei Q; Huang Z; Li G
Eur J Cancer; 2015 Jul; 51(11):1415-23. PubMed ID: 25981582
[TBL] [Abstract][Full Text] [Related]
18. TGFβ1 Polymorphisms Predict Distant Metastasis-Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy.
Yuan X; Wei Q; Komaki R; Liu Z; Yang J; Tucker SL; Xu T; Heymach JV; Lu C; Cox JD; Liao Z
PLoS One; 2013; 8(6):e65659. PubMed ID: 23840350
[TBL] [Abstract][Full Text] [Related]
19. A functional variant at miRNA-122 binding site in IL-1a 3' UTR predicts risk of recurrence in patients with oropharyngeal cancer.
Wang C; Sturgis EM; Chen X; Wei Q; Li G
Oncotarget; 2016 Jun; 7(23):34472-9. PubMed ID: 27121322
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy.
Zhang F; Sturgis EM; Sun Y; Zhang Y; Wei Q; Zhang C; Zheng H; Li G
Int J Cancer; 2015 Nov; 137(10):2454-61. PubMed ID: 25976983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
